Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases (Q46616119)
Jump to navigation
Jump to search
scientific article published in May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases |
scientific article published in May 2008 |
Statements
1 reference
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases (English)
1 reference
1 reference
1 reference
Zariana Nikolova
1 reference
George D Demetri
1 reference
Christopher L Corless
1 reference
Jane Apperley
1 reference
Jonathan A Fletcher
1 reference
Denis Soulieres
1 reference
Stephan Dirnhofer
1 reference
Amy Harlow
1 reference
Ajia Town
1 reference
Arin McKinley
1 reference
Shane G Supple
1 reference
John Seymour
1 reference
Lilla Di Scala
1 reference
Allan van Oosterom
1 reference
Richard Herrmann
1 reference
And Grant McArthur
1 reference
Imatinib Target Exploration Consortium Study B2225
1 reference
1 May 2008
1 reference
14
1 reference
9
1 reference
2717-2725
1 reference